nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP11B1—Phenytoin—epilepsy syndrome	0.154	0.202	CbGbCtD
Metyrapone—ABCC3—Phenobarbital—epilepsy syndrome	0.0765	0.1	CbGbCtD
Metyrapone—CYP2A6—Amobarbital—epilepsy syndrome	0.0477	0.0624	CbGbCtD
Metyrapone—CYP2E1—Felbamate—epilepsy syndrome	0.0415	0.0544	CbGbCtD
Metyrapone—CYP2E1—Trimethadione—epilepsy syndrome	0.0415	0.0544	CbGbCtD
Metyrapone—CYP2A6—Propofol—epilepsy syndrome	0.0355	0.0465	CbGbCtD
Metyrapone—CYP2E1—Clonazepam—epilepsy syndrome	0.0353	0.0462	CbGbCtD
Metyrapone—CYP2A6—Phenobarbital—epilepsy syndrome	0.034	0.0445	CbGbCtD
Metyrapone—CYP2E1—Rufinamide—epilepsy syndrome	0.0288	0.0377	CbGbCtD
Metyrapone—CYP2A6—Valproic Acid—epilepsy syndrome	0.0254	0.0332	CbGbCtD
Metyrapone—CYP2E1—Propofol—epilepsy syndrome	0.0234	0.0307	CbGbCtD
Metyrapone—CYP2E1—Phenobarbital—epilepsy syndrome	0.0224	0.0294	CbGbCtD
Metyrapone—CYP2E1—Midazolam—epilepsy syndrome	0.0221	0.0289	CbGbCtD
Metyrapone—CYP2E1—Diazepam—epilepsy syndrome	0.0212	0.0278	CbGbCtD
Metyrapone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0135	0.0177	CbGbCtD
Metyrapone—CYP3A4—Felbamate—epilepsy syndrome	0.0126	0.0165	CbGbCtD
Metyrapone—CYP3A4—Trimethadione—epilepsy syndrome	0.0126	0.0165	CbGbCtD
Metyrapone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0118	0.0155	CbGbCtD
Metyrapone—CYP3A4—Clonazepam—epilepsy syndrome	0.0107	0.014	CbGbCtD
Metyrapone—CYP3A4—Clobazam—epilepsy syndrome	0.0103	0.0134	CbGbCtD
Metyrapone—CYP3A4—Rufinamide—epilepsy syndrome	0.00872	0.0114	CbGbCtD
Metyrapone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00849	0.0111	CbGbCtD
Metyrapone—CYP3A4—Primidone—epilepsy syndrome	0.00793	0.0104	CbGbCtD
Metyrapone—CYP3A4—Phenytoin—epilepsy syndrome	0.00762	0.00998	CbGbCtD
Metyrapone—CYP3A4—Propofol—epilepsy syndrome	0.00711	0.00931	CbGbCtD
Metyrapone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00679	0.00889	CbGbCtD
Metyrapone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00679	0.00889	CbGbCtD
Metyrapone—CYP3A4—Midazolam—epilepsy syndrome	0.0067	0.00877	CbGbCtD
Metyrapone—CYP3A4—Diazepam—epilepsy syndrome	0.00644	0.00843	CbGbCtD
Metyrapone—CYP3A4—Zonisamide—epilepsy syndrome	0.00628	0.00823	CbGbCtD
Metyrapone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00507	0.00665	CbGbCtD
Metyrapone—CYP3A4—Topiramate—epilepsy syndrome	0.00458	0.006	CbGbCtD
Metyrapone—Abdominal pain—Trimethadione—epilepsy syndrome	0.000607	0.00424	CcSEcCtD
Metyrapone—Alopecia—Levetiracetam—epilepsy syndrome	0.000605	0.00423	CcSEcCtD
Metyrapone—Dizziness—Amobarbital—epilepsy syndrome	0.000599	0.00418	CcSEcCtD
Metyrapone—Nervous system disorder—Clobazam—epilepsy syndrome	0.000597	0.00417	CcSEcCtD
Metyrapone—Skin disorder—Clobazam—epilepsy syndrome	0.000591	0.00413	CcSEcCtD
Metyrapone—Pain—Phenobarbital—epilepsy syndrome	0.000582	0.00406	CcSEcCtD
Metyrapone—Dizziness—Primidone—epilepsy syndrome	0.000577	0.00403	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000576	0.00402	CcSEcCtD
Metyrapone—Vomiting—Amobarbital—epilepsy syndrome	0.000576	0.00402	CcSEcCtD
Metyrapone—Angiopathy—Diazepam—epilepsy syndrome	0.000576	0.00402	CcSEcCtD
Metyrapone—Hypotension—Clobazam—epilepsy syndrome	0.000568	0.00397	CcSEcCtD
Metyrapone—Headache—Amobarbital—epilepsy syndrome	0.000568	0.00396	CcSEcCtD
Metyrapone—Vomiting—Primidone—epilepsy syndrome	0.000555	0.00388	CcSEcCtD
Metyrapone—Headache—Primidone—epilepsy syndrome	0.000547	0.00382	CcSEcCtD
Metyrapone—Alopecia—Felbamate—epilepsy syndrome	0.000543	0.00379	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000541	0.00378	CcSEcCtD
Metyrapone—Nausea—Amobarbital—epilepsy syndrome	0.000538	0.00376	CcSEcCtD
Metyrapone—Hypertension—Propofol—epilepsy syndrome	0.000533	0.00372	CcSEcCtD
Metyrapone—Alopecia—Zonisamide—epilepsy syndrome	0.000531	0.00371	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000525	0.00367	CcSEcCtD
Metyrapone—Angiopathy—Oxcarbazepine—epilepsy syndrome	0.000519	0.00363	CcSEcCtD
Metyrapone—Nausea—Primidone—epilepsy syndrome	0.000519	0.00362	CcSEcCtD
Metyrapone—Alopecia—Clonazepam—epilepsy syndrome	0.000512	0.00357	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.00051	0.00356	CcSEcCtD
Metyrapone—Alopecia—Oxcarbazepine—epilepsy syndrome	0.000506	0.00353	CcSEcCtD
Metyrapone—Abdominal discomfort—Valproic Acid—epilepsy syndrome	0.000505	0.00353	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000504	0.00352	CcSEcCtD
Metyrapone—Pancytopenia—Valproic Acid—epilepsy syndrome	0.0005	0.00349	CcSEcCtD
Metyrapone—Angiopathy—Carbamazepine—epilepsy syndrome	0.000498	0.00348	CcSEcCtD
Metyrapone—Hypertension—Fosphenytoin—epilepsy syndrome	0.000497	0.00347	CcSEcCtD
Metyrapone—Vomiting—Trimethadione—epilepsy syndrome	0.000488	0.00341	CcSEcCtD
Metyrapone—Alopecia—Carbamazepine—epilepsy syndrome	0.000485	0.00339	CcSEcCtD
Metyrapone—Nervous system disorder—Midazolam—epilepsy syndrome	0.000483	0.00337	CcSEcCtD
Metyrapone—Angiopathy—Lamotrigine—epilepsy syndrome	0.000482	0.00336	CcSEcCtD
Metyrapone—Headache—Trimethadione—epilepsy syndrome	0.000481	0.00336	CcSEcCtD
Metyrapone—Skin disorder—Midazolam—epilepsy syndrome	0.000479	0.00334	CcSEcCtD
Metyrapone—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000477	0.00333	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.000474	0.00331	CcSEcCtD
Metyrapone—Skin disorder—Levetiracetam—epilepsy syndrome	0.000473	0.0033	CcSEcCtD
Metyrapone—Hypotension—Propofol—epilepsy syndrome	0.000471	0.00329	CcSEcCtD
Metyrapone—Alopecia—Lamotrigine—epilepsy syndrome	0.000469	0.00327	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000468	0.00327	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000467	0.00326	CcSEcCtD
Metyrapone—Hypertension—Felbamate—epilepsy syndrome	0.000461	0.00322	CcSEcCtD
Metyrapone—Hypotension—Midazolam—epilepsy syndrome	0.00046	0.00321	CcSEcCtD
Metyrapone—Nausea—Trimethadione—epilepsy syndrome	0.000456	0.00318	CcSEcCtD
Metyrapone—Pancytopenia—Pregabalin—epilepsy syndrome	0.000452	0.00316	CcSEcCtD
Metyrapone—Hypertension—Zonisamide—epilepsy syndrome	0.000452	0.00315	CcSEcCtD
Metyrapone—Dizziness—Phenobarbital—epilepsy syndrome	0.00045	0.00314	CcSEcCtD
Metyrapone—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000449	0.00313	CcSEcCtD
Metyrapone—Skin disorder—Vigabatrin—epilepsy syndrome	0.000445	0.0031	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000442	0.00309	CcSEcCtD
Metyrapone—Nervous system disorder—Diazepam—epilepsy syndrome	0.000442	0.00309	CcSEcCtD
Metyrapone—Dizziness—Rufinamide—epilepsy syndrome	0.000441	0.00308	CcSEcCtD
Metyrapone—Hypotension—Fosphenytoin—epilepsy syndrome	0.000439	0.00306	CcSEcCtD
Metyrapone—Skin disorder—Diazepam—epilepsy syndrome	0.000438	0.00306	CcSEcCtD
Metyrapone—Vomiting—Phenobarbital—epilepsy syndrome	0.000432	0.00302	CcSEcCtD
Metyrapone—Hypertension—Phenytoin—epilepsy syndrome	0.000432	0.00302	CcSEcCtD
Metyrapone—Pain—Propofol—epilepsy syndrome	0.000431	0.00301	CcSEcCtD
Metyrapone—Hypertension—Oxcarbazepine—epilepsy syndrome	0.00043	0.003	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000426	0.00298	CcSEcCtD
Metyrapone—Headache—Phenobarbital—epilepsy syndrome	0.000426	0.00297	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000425	0.00297	CcSEcCtD
Metyrapone—Vomiting—Rufinamide—epilepsy syndrome	0.000424	0.00296	CcSEcCtD
Metyrapone—Pain—Midazolam—epilepsy syndrome	0.000421	0.00294	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000421	0.00294	CcSEcCtD
Metyrapone—Hypotension—Diazepam—epilepsy syndrome	0.000421	0.00294	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.00042	0.00293	CcSEcCtD
Metyrapone—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000419	0.00292	CcSEcCtD
Metyrapone—Headache—Rufinamide—epilepsy syndrome	0.000418	0.00292	CcSEcCtD
Metyrapone—Pain—Levetiracetam—epilepsy syndrome	0.000416	0.00291	CcSEcCtD
Metyrapone—Skin disorder—Zonisamide—epilepsy syndrome	0.000415	0.0029	CcSEcCtD
Metyrapone—Dizziness—Lacosamide—epilepsy syndrome	0.000415	0.00289	CcSEcCtD
Metyrapone—Hypertension—Carbamazepine—epilepsy syndrome	0.000413	0.00288	CcSEcCtD
Metyrapone—Hypotension—Felbamate—epilepsy syndrome	0.000408	0.00285	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000404	0.00282	CcSEcCtD
Metyrapone—Nausea—Phenobarbital—epilepsy syndrome	0.000404	0.00282	CcSEcCtD
Metyrapone—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000404	0.00282	CcSEcCtD
Metyrapone—Dizziness—Clobazam—epilepsy syndrome	0.000402	0.00281	CcSEcCtD
Metyrapone—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000401	0.0028	CcSEcCtD
Metyrapone—Skin disorder—Clonazepam—epilepsy syndrome	0.0004	0.00279	CcSEcCtD
Metyrapone—Hypotension—Zonisamide—epilepsy syndrome	0.000399	0.00279	CcSEcCtD
Metyrapone—Hypertension—Lamotrigine—epilepsy syndrome	0.000399	0.00279	CcSEcCtD
Metyrapone—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000399	0.00278	CcSEcCtD
Metyrapone—Vomiting—Lacosamide—epilepsy syndrome	0.000399	0.00278	CcSEcCtD
Metyrapone—Abdominal pain—Propofol—epilepsy syndrome	0.000398	0.00278	CcSEcCtD
Metyrapone—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000398	0.00278	CcSEcCtD
Metyrapone—Nausea—Rufinamide—epilepsy syndrome	0.000397	0.00277	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000395	0.00276	CcSEcCtD
Metyrapone—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000395	0.00276	CcSEcCtD
Metyrapone—Headache—Lacosamide—epilepsy syndrome	0.000393	0.00274	CcSEcCtD
Metyrapone—Pain—Vigabatrin—epilepsy syndrome	0.000391	0.00273	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000389	0.00272	CcSEcCtD
Metyrapone—Vomiting—Clobazam—epilepsy syndrome	0.000387	0.0027	CcSEcCtD
Metyrapone—Pain—Diazepam—epilepsy syndrome	0.000385	0.00269	CcSEcCtD
Metyrapone—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000385	0.00269	CcSEcCtD
Metyrapone—Hypotension—Clonazepam—epilepsy syndrome	0.000385	0.00268	CcSEcCtD
Metyrapone—Angiopathy—Valproic Acid—epilepsy syndrome	0.000383	0.00267	CcSEcCtD
Metyrapone—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000383	0.00267	CcSEcCtD
Metyrapone—Hypotension—Phenytoin—epilepsy syndrome	0.000382	0.00267	CcSEcCtD
Metyrapone—Headache—Clobazam—epilepsy syndrome	0.000381	0.00266	CcSEcCtD
Metyrapone—Hypotension—Oxcarbazepine—epilepsy syndrome	0.00038	0.00265	CcSEcCtD
Metyrapone—Skin disorder—Carbamazepine—epilepsy syndrome	0.000379	0.00265	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000374	0.00261	CcSEcCtD
Metyrapone—Pain—Felbamate—epilepsy syndrome	0.000373	0.0026	CcSEcCtD
Metyrapone—Alopecia—Valproic Acid—epilepsy syndrome	0.000373	0.0026	CcSEcCtD
Metyrapone—Nausea—Lacosamide—epilepsy syndrome	0.000372	0.0026	CcSEcCtD
Metyrapone—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00037	0.00258	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000369	0.00257	CcSEcCtD
Metyrapone—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000369	0.00257	CcSEcCtD
Metyrapone—Hypotension—Carbamazepine—epilepsy syndrome	0.000365	0.00255	CcSEcCtD
Metyrapone—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000362	0.00253	CcSEcCtD
Metyrapone—Nausea—Clobazam—epilepsy syndrome	0.000361	0.00252	CcSEcCtD
Metyrapone—Dizziness—Acetazolamide—epilepsy syndrome	0.000359	0.0025	CcSEcCtD
Metyrapone—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000357	0.00249	CcSEcCtD
Metyrapone—Abdominal pain—Diazepam—epilepsy syndrome	0.000356	0.00249	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000355	0.00248	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000353	0.00246	CcSEcCtD
Metyrapone—Niacin—CYP2D6—epilepsy syndrome	0.000353	1	CrCbGaD
Metyrapone—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000352	0.00246	CcSEcCtD
Metyrapone—Pain—Clonazepam—epilepsy syndrome	0.000352	0.00246	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000351	0.00245	CcSEcCtD
Metyrapone—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000349	0.00244	CcSEcCtD
Metyrapone—Pancytopenia—Topiramate—epilepsy syndrome	0.000349	0.00244	CcSEcCtD
Metyrapone—Pain—Oxcarbazepine—epilepsy syndrome	0.000348	0.00243	CcSEcCtD
Metyrapone—Angiopathy—Pregabalin—epilepsy syndrome	0.000346	0.00242	CcSEcCtD
Metyrapone—Abdominal pain—Felbamate—epilepsy syndrome	0.000345	0.00241	CcSEcCtD
Metyrapone—Vomiting—Acetazolamide—epilepsy syndrome	0.000345	0.00241	CcSEcCtD
Metyrapone—Headache—Acetazolamide—epilepsy syndrome	0.00034	0.00237	CcSEcCtD
Metyrapone—Abdominal pain—Zonisamide—epilepsy syndrome	0.000338	0.00236	CcSEcCtD
Metyrapone—Alopecia—Pregabalin—epilepsy syndrome	0.000337	0.00235	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000337	0.00235	CcSEcCtD
Metyrapone—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000336	0.00235	CcSEcCtD
Metyrapone—Pain—Carbamazepine—epilepsy syndrome	0.000334	0.00233	CcSEcCtD
Metyrapone—Dizziness—Propofol—epilepsy syndrome	0.000333	0.00233	CcSEcCtD
Metyrapone—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000332	0.00232	CcSEcCtD
Metyrapone—Dizziness—Midazolam—epilepsy syndrome	0.000326	0.00228	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000326	0.00227	CcSEcCtD
Metyrapone—Abdominal pain—Clonazepam—epilepsy syndrome	0.000325	0.00227	CcSEcCtD
Metyrapone—Pain—Lamotrigine—epilepsy syndrome	0.000322	0.00225	CcSEcCtD
Metyrapone—Nausea—Acetazolamide—epilepsy syndrome	0.000322	0.00225	CcSEcCtD
Metyrapone—Dizziness—Levetiracetam—epilepsy syndrome	0.000322	0.00225	CcSEcCtD
Metyrapone—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000321	0.00224	CcSEcCtD
Metyrapone—Vomiting—Propofol—epilepsy syndrome	0.00032	0.00224	CcSEcCtD
Metyrapone—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000319	0.00223	CcSEcCtD
Metyrapone—Hypertension—Valproic Acid—epilepsy syndrome	0.000317	0.00221	CcSEcCtD
Metyrapone—Headache—Propofol—epilepsy syndrome	0.000316	0.0022	CcSEcCtD
Metyrapone—Vomiting—Midazolam—epilepsy syndrome	0.000313	0.00219	CcSEcCtD
Metyrapone—Dizziness—Fosphenytoin—epilepsy syndrome	0.000311	0.00217	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.00031	0.00217	CcSEcCtD
Metyrapone—Vomiting—Levetiracetam—epilepsy syndrome	0.000309	0.00216	CcSEcCtD
Metyrapone—Alopecia—Gabapentin—epilepsy syndrome	0.000309	0.00216	CcSEcCtD
Metyrapone—Headache—Midazolam—epilepsy syndrome	0.000309	0.00216	CcSEcCtD
Metyrapone—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000308	0.00215	CcSEcCtD
Metyrapone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000308	0.00215	CcSEcCtD
Metyrapone—Headache—Levetiracetam—epilepsy syndrome	0.000305	0.00213	CcSEcCtD
Metyrapone—Dizziness—Vigabatrin—epilepsy syndrome	0.000303	0.00211	CcSEcCtD
Metyrapone—Nausea—Propofol—epilepsy syndrome	0.000299	0.00209	CcSEcCtD
Metyrapone—Vomiting—Fosphenytoin—epilepsy syndrome	0.000299	0.00208	CcSEcCtD
Metyrapone—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000298	0.00208	CcSEcCtD
Metyrapone—Dizziness—Diazepam—epilepsy syndrome	0.000298	0.00208	CcSEcCtD
Metyrapone—Headache—Fosphenytoin—epilepsy syndrome	0.000294	0.00205	CcSEcCtD
Metyrapone—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000294	0.00205	CcSEcCtD
Metyrapone—Nausea—Midazolam—epilepsy syndrome	0.000293	0.00204	CcSEcCtD
Metyrapone—Vomiting—Vigabatrin—epilepsy syndrome	0.000291	0.00203	CcSEcCtD
Metyrapone—Skin disorder—Valproic Acid—epilepsy syndrome	0.000291	0.00203	CcSEcCtD
Metyrapone—Nausea—Levetiracetam—epilepsy syndrome	0.000289	0.00202	CcSEcCtD
Metyrapone—Dizziness—Felbamate—epilepsy syndrome	0.000288	0.00201	CcSEcCtD
Metyrapone—Headache—Vigabatrin—epilepsy syndrome	0.000287	0.002	CcSEcCtD
Metyrapone—Hypertension—Pregabalin—epilepsy syndrome	0.000287	0.002	CcSEcCtD
Metyrapone—Vomiting—Diazepam—epilepsy syndrome	0.000287	0.002	CcSEcCtD
Metyrapone—Dizziness—Zonisamide—epilepsy syndrome	0.000282	0.00197	CcSEcCtD
Metyrapone—Headache—Diazepam—epilepsy syndrome	0.000282	0.00197	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000281	0.00196	CcSEcCtD
Metyrapone—Hypotension—Valproic Acid—epilepsy syndrome	0.00028	0.00195	CcSEcCtD
Metyrapone—Nausea—Fosphenytoin—epilepsy syndrome	0.000279	0.00195	CcSEcCtD
Metyrapone—Vomiting—Felbamate—epilepsy syndrome	0.000277	0.00194	CcSEcCtD
Metyrapone—Headache—Felbamate—epilepsy syndrome	0.000273	0.00191	CcSEcCtD
Metyrapone—Dizziness—Clonazepam—epilepsy syndrome	0.000272	0.0019	CcSEcCtD
Metyrapone—Nausea—Vigabatrin—epilepsy syndrome	0.000272	0.0019	CcSEcCtD
Metyrapone—Vomiting—Zonisamide—epilepsy syndrome	0.000271	0.0019	CcSEcCtD
Metyrapone—Dizziness—Phenytoin—epilepsy syndrome	0.00027	0.00189	CcSEcCtD
Metyrapone—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000269	0.00188	CcSEcCtD
Metyrapone—Nausea—Diazepam—epilepsy syndrome	0.000268	0.00187	CcSEcCtD
Metyrapone—Headache—Zonisamide—epilepsy syndrome	0.000267	0.00187	CcSEcCtD
Metyrapone—Angiopathy—Topiramate—epilepsy syndrome	0.000267	0.00186	CcSEcCtD
Metyrapone—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000266	0.00185	CcSEcCtD
Metyrapone—Skin disorder—Pregabalin—epilepsy syndrome	0.000263	0.00184	CcSEcCtD
Metyrapone—Hypertension—Gabapentin—epilepsy syndrome	0.000263	0.00183	CcSEcCtD
Metyrapone—Vomiting—Clonazepam—epilepsy syndrome	0.000262	0.00183	CcSEcCtD
Metyrapone—Alopecia—Topiramate—epilepsy syndrome	0.00026	0.00181	CcSEcCtD
Metyrapone—Vomiting—Phenytoin—epilepsy syndrome	0.00026	0.00181	CcSEcCtD
Metyrapone—Nausea—Felbamate—epilepsy syndrome	0.000259	0.00181	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000259	0.00181	CcSEcCtD
Metyrapone—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000259	0.0018	CcSEcCtD
Metyrapone—Dizziness—Carbamazepine—epilepsy syndrome	0.000258	0.0018	CcSEcCtD
Metyrapone—Headache—Clonazepam—epilepsy syndrome	0.000258	0.0018	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000257	0.0018	CcSEcCtD
Metyrapone—Pain—Valproic Acid—epilepsy syndrome	0.000256	0.00179	CcSEcCtD
Metyrapone—Headache—Phenytoin—epilepsy syndrome	0.000256	0.00179	CcSEcCtD
Metyrapone—Headache—Oxcarbazepine—epilepsy syndrome	0.000255	0.00178	CcSEcCtD
Metyrapone—Nausea—Zonisamide—epilepsy syndrome	0.000254	0.00177	CcSEcCtD
Metyrapone—Hypotension—Pregabalin—epilepsy syndrome	0.000253	0.00177	CcSEcCtD
Metyrapone—Dizziness—Lamotrigine—epilepsy syndrome	0.000249	0.00174	CcSEcCtD
Metyrapone—Vomiting—Carbamazepine—epilepsy syndrome	0.000248	0.00173	CcSEcCtD
Metyrapone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000245	0.00171	CcSEcCtD
Metyrapone—Nausea—Clonazepam—epilepsy syndrome	0.000244	0.00171	CcSEcCtD
Metyrapone—Headache—Carbamazepine—epilepsy syndrome	0.000244	0.00171	CcSEcCtD
Metyrapone—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000244	0.0017	CcSEcCtD
Metyrapone—Nausea—Phenytoin—epilepsy syndrome	0.000243	0.0017	CcSEcCtD
Metyrapone—Nausea—Oxcarbazepine—epilepsy syndrome	0.000241	0.00169	CcSEcCtD
Metyrapone—Skin disorder—Gabapentin—epilepsy syndrome	0.000241	0.00168	CcSEcCtD
Metyrapone—Vomiting—Lamotrigine—epilepsy syndrome	0.00024	0.00167	CcSEcCtD
Metyrapone—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000237	0.00165	CcSEcCtD
Metyrapone—Headache—Lamotrigine—epilepsy syndrome	0.000236	0.00165	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000234	0.00163	CcSEcCtD
Metyrapone—Hypotension—Gabapentin—epilepsy syndrome	0.000232	0.00162	CcSEcCtD
Metyrapone—Nausea—Carbamazepine—epilepsy syndrome	0.000232	0.00162	CcSEcCtD
Metyrapone—Pain—Pregabalin—epilepsy syndrome	0.000232	0.00162	CcSEcCtD
Metyrapone—Nausea—Lamotrigine—epilepsy syndrome	0.000224	0.00156	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000222	0.00155	CcSEcCtD
Metyrapone—Hypertension—Topiramate—epilepsy syndrome	0.000221	0.00154	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000216	0.00151	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000214	0.0015	CcSEcCtD
Metyrapone—Abdominal pain—Pregabalin—epilepsy syndrome	0.000214	0.0015	CcSEcCtD
Metyrapone—Pain—Gabapentin—epilepsy syndrome	0.000212	0.00148	CcSEcCtD
Metyrapone—Nervous system disorder—Topiramate—epilepsy syndrome	0.000205	0.00143	CcSEcCtD
Metyrapone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000203	0.00142	CcSEcCtD
Metyrapone—Skin disorder—Topiramate—epilepsy syndrome	0.000203	0.00142	CcSEcCtD
Metyrapone—Dizziness—Valproic Acid—epilepsy syndrome	0.000198	0.00138	CcSEcCtD
Metyrapone—Abdominal pain—Gabapentin—epilepsy syndrome	0.000196	0.00137	CcSEcCtD
Metyrapone—Hypotension—Topiramate—epilepsy syndrome	0.000195	0.00136	CcSEcCtD
Metyrapone—Vomiting—Valproic Acid—epilepsy syndrome	0.000191	0.00133	CcSEcCtD
Metyrapone—Headache—Valproic Acid—epilepsy syndrome	0.000188	0.00131	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.00018	0.00126	CcSEcCtD
Metyrapone—Dizziness—Pregabalin—epilepsy syndrome	0.000179	0.00125	CcSEcCtD
Metyrapone—Pain—Topiramate—epilepsy syndrome	0.000179	0.00125	CcSEcCtD
Metyrapone—Nausea—Valproic Acid—epilepsy syndrome	0.000178	0.00124	CcSEcCtD
Metyrapone—Vomiting—Pregabalin—epilepsy syndrome	0.000172	0.0012	CcSEcCtD
Metyrapone—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000171	0.00119	CcSEcCtD
Metyrapone—Headache—Pregabalin—epilepsy syndrome	0.00017	0.00118	CcSEcCtD
Metyrapone—Abdominal pain—Topiramate—epilepsy syndrome	0.000165	0.00115	CcSEcCtD
Metyrapone—Dizziness—Gabapentin—epilepsy syndrome	0.000164	0.00115	CcSEcCtD
Metyrapone—Nausea—Pregabalin—epilepsy syndrome	0.000161	0.00112	CcSEcCtD
Metyrapone—Vomiting—Gabapentin—epilepsy syndrome	0.000158	0.0011	CcSEcCtD
Metyrapone—Headache—Gabapentin—epilepsy syndrome	0.000156	0.00109	CcSEcCtD
Metyrapone—Nausea—Gabapentin—epilepsy syndrome	0.000148	0.00103	CcSEcCtD
Metyrapone—Dizziness—Topiramate—epilepsy syndrome	0.000138	0.000965	CcSEcCtD
Metyrapone—Vomiting—Topiramate—epilepsy syndrome	0.000133	0.000928	CcSEcCtD
Metyrapone—Headache—Topiramate—epilepsy syndrome	0.000131	0.000914	CcSEcCtD
Metyrapone—Nausea—Topiramate—epilepsy syndrome	0.000124	0.000867	CcSEcCtD
Metyrapone—CYP2A6—Biological oxidations—POMC—epilepsy syndrome	3.7e-05	0.000399	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP11A1—epilepsy syndrome	3.69e-05	0.000397	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.67e-05	0.000395	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADSL—epilepsy syndrome	3.67e-05	0.000395	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.66e-05	0.000394	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GLUL—epilepsy syndrome	3.59e-05	0.000387	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CACNA1D—epilepsy syndrome	3.53e-05	0.00038	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—COX3—epilepsy syndrome	3.49e-05	0.000376	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—L2HGDH—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FAR1—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CERS1—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GLUD1—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADK—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PDXK—epilepsy syndrome	3.45e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.34e-05	0.000359	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP2D6—epilepsy syndrome	3.33e-05	0.000358	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLCO1A2—epilepsy syndrome	3.31e-05	0.000357	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PFKL—epilepsy syndrome	3.31e-05	0.000357	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CACNA2D2—epilepsy syndrome	3.31e-05	0.000357	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—KCNB1—epilepsy syndrome	3.31e-05	0.000357	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC6A8—epilepsy syndrome	3.31e-05	0.000357	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TXNRD1—epilepsy syndrome	3.3e-05	0.000355	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCG2—epilepsy syndrome	3.28e-05	0.000353	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.28e-05	0.000353	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.25e-05	0.00035	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AQP1—epilepsy syndrome	3.2e-05	0.000345	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP2C19—epilepsy syndrome	3.2e-05	0.000344	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP11A1—epilepsy syndrome	3.18e-05	0.000342	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ADRA2A—epilepsy syndrome	3.17e-05	0.000341	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—EPM2A—epilepsy syndrome	3.16e-05	0.00034	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GAMT—epilepsy syndrome	3.16e-05	0.00034	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NHLRC1—epilepsy syndrome	3.16e-05	0.00034	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PNPO—epilepsy syndrome	3.16e-05	0.00034	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.15e-05	0.000339	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.15e-05	0.000339	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—BCHE—epilepsy syndrome	3.15e-05	0.000339	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.15e-05	0.000339	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.09e-05	0.000333	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.08e-05	0.000331	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.07e-05	0.000331	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.05e-05	0.000328	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.03e-05	0.000326	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—UPB1—epilepsy syndrome	3.03e-05	0.000326	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NEU1—epilepsy syndrome	3.03e-05	0.000326	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ATIC—epilepsy syndrome	3.03e-05	0.000326	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SLC2A1—epilepsy syndrome	3.01e-05	0.000324	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PLCB1—epilepsy syndrome	2.98e-05	0.00032	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TH—epilepsy syndrome	2.97e-05	0.000319	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA4—epilepsy syndrome	2.94e-05	0.000316	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—QDPR—epilepsy syndrome	2.94e-05	0.000316	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—POMC—epilepsy syndrome	2.93e-05	0.000315	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.92e-05	0.000314	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HSD17B4—epilepsy syndrome	2.92e-05	0.000314	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CHRM3—epilepsy syndrome	2.9e-05	0.000312	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—KCNJ11—epilepsy syndrome	2.9e-05	0.000312	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.88e-05	0.000309	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP2D6—epilepsy syndrome	2.87e-05	0.000309	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GBE1—epilepsy syndrome	2.82e-05	0.000303	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP1R3C—epilepsy syndrome	2.82e-05	0.000303	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.77e-05	0.000298	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—COX3—epilepsy syndrome	2.76e-05	0.000297	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.73e-05	0.000294	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ADRA2A—epilepsy syndrome	2.73e-05	0.000294	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—BCHE—epilepsy syndrome	2.72e-05	0.000293	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.7e-05	0.00029	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ASAH1—epilepsy syndrome	2.65e-05	0.000285	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.64e-05	0.000285	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC6A8—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CACNA2D2—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PFKL—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLCO1A2—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—KCNB1—epilepsy syndrome	2.62e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—SLC2A1—epilepsy syndrome	2.59e-05	0.000279	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—STXBP1—epilepsy syndrome	2.58e-05	0.000277	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PLCB1—epilepsy syndrome	2.56e-05	0.000276	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.56e-05	0.000275	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TH—epilepsy syndrome	2.56e-05	0.000275	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.52e-05	0.000271	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NT5E—epilepsy syndrome	2.51e-05	0.00027	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALAD—epilepsy syndrome	2.51e-05	0.00027	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—HMOX1—epilepsy syndrome	2.47e-05	0.000266	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAT—epilepsy syndrome	2.44e-05	0.000263	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALDH7A1—epilepsy syndrome	2.39e-05	0.000258	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CACNA1A—epilepsy syndrome	2.39e-05	0.000258	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ATIC—epilepsy syndrome	2.39e-05	0.000258	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NEU1—epilepsy syndrome	2.39e-05	0.000258	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—UPB1—epilepsy syndrome	2.39e-05	0.000258	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCB1—epilepsy syndrome	2.38e-05	0.000256	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCG2—epilepsy syndrome	2.36e-05	0.000254	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ST3GAL3—epilepsy syndrome	2.34e-05	0.000252	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HSD17B4—epilepsy syndrome	2.3e-05	0.000248	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP2C19—epilepsy syndrome	2.3e-05	0.000248	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADSL—epilepsy syndrome	2.3e-05	0.000247	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP11A1—epilepsy syndrome	2.29e-05	0.000246	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.27e-05	0.000244	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GLUL—epilepsy syndrome	2.25e-05	0.000242	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP1R3C—epilepsy syndrome	2.23e-05	0.00024	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GBE1—epilepsy syndrome	2.23e-05	0.00024	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CACNA1D—epilepsy syndrome	2.21e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPX1—epilepsy syndrome	2.21e-05	0.000238	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—HMOX1—epilepsy syndrome	2.13e-05	0.00023	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.11e-05	0.000228	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAT—epilepsy syndrome	2.1e-05	0.000226	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ASAH1—epilepsy syndrome	2.09e-05	0.000225	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.07e-05	0.000223	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	2.07e-05	0.000222	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP2D6—epilepsy syndrome	2.06e-05	0.000222	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCB1—epilepsy syndrome	2.05e-05	0.00022	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—STXBP1—epilepsy syndrome	2.04e-05	0.000219	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AQP1—epilepsy syndrome	2.01e-05	0.000216	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NT5E—epilepsy syndrome	1.98e-05	0.000214	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALAD—epilepsy syndrome	1.98e-05	0.000214	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.97e-05	0.000212	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADRA2A—epilepsy syndrome	1.97e-05	0.000212	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—BCHE—epilepsy syndrome	1.96e-05	0.000211	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AGT—epilepsy syndrome	1.94e-05	0.000208	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPX1—epilepsy syndrome	1.9e-05	0.000205	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—APOE—epilepsy syndrome	1.9e-05	0.000204	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	1.89e-05	0.000204	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	1.89e-05	0.000204	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC2A1—epilepsy syndrome	1.87e-05	0.000201	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	1.85e-05	0.000199	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PLCB1—epilepsy syndrome	1.85e-05	0.000199	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TH—epilepsy syndrome	1.84e-05	0.000198	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	1.81e-05	0.000195	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	1.81e-05	0.000195	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADSL—epilepsy syndrome	1.81e-05	0.000195	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.81e-05	0.000195	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GLUL—epilepsy syndrome	1.78e-05	0.000192	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	1.75e-05	0.000188	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AGT—epilepsy syndrome	1.67e-05	0.00018	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOE—epilepsy syndrome	1.64e-05	0.000176	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	1.63e-05	0.000176	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POMC—epilepsy syndrome	1.63e-05	0.000175	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.6e-05	0.000172	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AQP1—epilepsy syndrome	1.59e-05	0.000171	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HMOX1—epilepsy syndrome	1.54e-05	0.000165	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAT—epilepsy syndrome	1.52e-05	0.000163	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—epilepsy syndrome	1.49e-05	0.00016	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	1.48e-05	0.000159	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCB1—epilepsy syndrome	1.47e-05	0.000159	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.47e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.47e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.47e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.47e-05	0.000158	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	1.44e-05	0.000155	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	1.43e-05	0.000154	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	1.43e-05	0.000154	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	1.43e-05	0.000154	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POMC—epilepsy syndrome	1.4e-05	0.000151	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—epilepsy syndrome	1.37e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.36e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.36e-05	0.000147	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.36e-05	0.000146	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—epilepsy syndrome	1.3e-05	0.00014	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	1.29e-05	0.000139	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.28e-05	0.000138	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—epilepsy syndrome	1.28e-05	0.000138	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	1.23e-05	0.000133	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.000132	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.21e-05	0.000131	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AGT—epilepsy syndrome	1.2e-05	0.000129	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOE—epilepsy syndrome	1.18e-05	0.000127	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000126	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	1.17e-05	0.000126	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000125	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TH—epilepsy syndrome	1.15e-05	0.000124	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	1.14e-05	0.000123	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	1.13e-05	0.000122	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—epilepsy syndrome	1.12e-05	0.000121	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.11e-05	0.00012	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.11e-05	0.00012	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.11e-05	0.00012	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.07e-05	0.000115	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.03e-05	0.000111	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.03e-05	0.000111	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	1.02e-05	0.00011	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POMC—epilepsy syndrome	1.01e-05	0.000109	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	9.73e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9.71e-06	0.000104	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—BCHE—epilepsy syndrome	9.69e-06	0.000104	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	9.62e-06	0.000104	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAT—epilepsy syndrome	9.49e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.44e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	9.24e-06	9.95e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	9.23e-06	9.94e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—epilepsy syndrome	9.22e-06	9.92e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	9.2e-06	9.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	9.2e-06	9.91e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	9.14e-06	9.84e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TH—epilepsy syndrome	9.11e-06	9.8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.78e-06	9.45e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.78e-06	9.45e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	8.59e-06	9.25e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—epilepsy syndrome	8.58e-06	9.24e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.42e-06	9.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.26e-06	8.89e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.1e-06	8.72e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—epilepsy syndrome	8.07e-06	8.68e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	7.6e-06	8.18e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.58e-06	8.16e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGT—epilepsy syndrome	7.53e-06	8.1e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAT—epilepsy syndrome	7.5e-06	8.07e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOE—epilepsy syndrome	7.37e-06	7.94e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.36e-06	7.92e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	7.3e-06	7.85e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—epilepsy syndrome	6.78e-06	7.3e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.65e-06	7.16e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.65e-06	7.16e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—epilepsy syndrome	6.53e-06	7.03e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POMC—epilepsy syndrome	6.34e-06	6.82e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGT—epilepsy syndrome	5.95e-06	6.4e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOE—epilepsy syndrome	5.83e-06	6.27e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—epilepsy syndrome	5.78e-06	6.22e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—epilepsy syndrome	5.63e-06	6.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.42e-06	5.84e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.29e-06	5.69e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.25e-06	5.65e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	5.05e-06	5.44e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POMC—epilepsy syndrome	5.01e-06	5.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.74e-06	5.1e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—epilepsy syndrome	4.56e-06	4.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.51e-06	4.86e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.49e-06	4.84e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.29e-06	4.62e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.24e-06	4.56e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TH—epilepsy syndrome	4.23e-06	4.55e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—epilepsy syndrome	4.05e-06	4.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	3.99e-06	4.3e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.53e-06	3.8e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.48e-06	3.75e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.39e-06	3.64e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.15e-06	3.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.76e-06	2.97e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.7e-06	2.91e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—epilepsy syndrome	2.54e-06	2.73e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.32e-06	2.5e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.12e-06	2.28e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.01e-06	2.16e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.85e-06	1.99e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.31e-07	1e-05	CbGpPWpGaD
